Advanced Technology for Vital Treatment
The demands on a thoracic surgeon are intense and require the most advanced technology. While you’re saving lives, we’re innovating to bring you next-generation solutions. Together we will improve patient outcomes.
To work near the body’s most vital organs, you need empowering technology. The AirSeal® System is the first system cleared by the FDA for thoracic insufflation. AirSeal® provides constant pressure control, which keeps the lungs and diaphragm down for enhanced exposure even during continuous suction. The valve-free access design eliminates fragmentation during node retrieval.
1 Low Insufflation Pressure Cholecystectomy - Using an insufflation management system versus standard CO2 pneumoperitoneum. Rashid M. Kikhia MD, Kristie Price, Vamsi Alli MD, Aurora Pryor MD, Gerald Gracia MD, Jerry Rubano MD, Jessica Schnur MD, Dana Telem MD. SAGES Published Abstract.
2 Feasibility of robot-assisted prostatectomy performed at ultra-low pneumoperitoneum pressure of 6 mmHg and comparison of clinical outcomes vs standard pressure of 15 mmHg. Ferroni MC, Abaza R. BJU Int. 2019 Jan 17. doi: 10.1111/bju.14682. [Epub ahead of print].
3 A prospective, randomized, clinical study comparing AirSeal vs. Standard Insufflation in Minimally Invasive Urology, Gynecology, and General Surgery. Data on File.
4 Low pressure gynecological laparoscopy (7mmHg) with AirSeal® System versus a standard insufflation (15mmHg): A pilot study in 60 patients. Sroussi J, Elies A, Rigouzzo A, Louvet N, Mezzadri M, Fazel A, Benifla JL. Gynecol Obstet Hum Reprod. 2017 Feb;46(2):155-158.
5 Less is More: Clinical Impact of Decreasing Pneumoperitoneum Pressures during Robotic-Assisted Gynecologic Surgery. Huang J, Foley CE,* Ryan EM, Prunty LE, Arslan AA. Published AAGL Abstract.
